A Phase 1 Trial of CBL0137 in Patients With Metastatic or Unresectable Advanced Solid Neoplasm
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- John Sarantopoulos, MD
The University of Texas Health Science Center at San Antonio
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Roswell Park Cancer Institute
Buffalo, New York, United States
- Cleveland Clinic
Cleveland, Ohio, United States
- University Hospital of Cleveland
Cleveland, Ohio, United States
- Ctrc at the University of Texas Healh Science Center at San Antonio
San Antonio, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2013
- Primary completion
- 31 May 2019
- Completion
- 30 Jun 2019
- Last update posted
- 10 Dec 2020
- Registered enrollment
- 83
- Registry id
- NCT01905228
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.